🔎 Trials Near Me

Beranda › Kejang › Michigan

Uji klinis Kejang di Michigan

7 studi untuk Kejang mencari peserta di lokasi di Michigan.

Kota di Michigan

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Wayne State University, Detroit
  • Corewell Health, Grand Rapids
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Wayne State University - Detroit Medical Center, Detroit
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06798896

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

  • C.S. Mott Children's Hospital, Ann Arbor
Menerima pesertaStudi observasional
Hingga usia 26 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05374824

Outcomes After Planned Discontinuation of AntiSeizure Medication

  • University of Michigan, Ann Arbor
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07750496

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program, Detroit
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • 9D University Health Center, Detroit
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Michigan, Ann Arbor
Menerima pesertaFase 3
6 Months – 13 Years · Semua jenis kelamin · Diperbarui 30 Sep 2025 · NCT05121324

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.